Status:
UNKNOWN
Daily Life Activities in Patients Treated With Continuous-Flow Left Ventricular Assist Devices
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Left Ventricular Failure, Unspecified
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
Investigation of oxygen uptake during daily life activities in HF patients with and without LVADs.
Detailed Description
In patients with terminal HF the gold standard for treatment is heart transplantation, though the Worldwide shortage of donor organs has led to increased use of implantable mechanical circulatory supp...
Eligibility Criteria
Inclusion
- LVADs:
- Implanted durable left ventricular assist device
- Age\>18yrs
- Signed informed consent
Exclusion
- No consent
- Not able to complete VO2 test (physicians decision)
Key Trial Info
Start Date :
February 8 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04732039
Start Date
February 8 2021
End Date
December 31 2022
Last Update
February 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet
Copenhagen, DK, Denmark, 2100